443 related articles for article (PubMed ID: 20684722)
21. Rotavirus vaccines: entering a new stage of deployment.
Nakagomi O; Cunliffe NA
Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
[TBL] [Abstract][Full Text] [Related]
22. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
[TBL] [Abstract][Full Text] [Related]
23. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
24. Rotavirus vaccination: a concise review.
Vesikari T
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():57-63. PubMed ID: 22882248
[TBL] [Abstract][Full Text] [Related]
25. A short report on highlights of world-wide development of RIX4414: a Latin American experience.
Linhares AC; Ruiz-Palacios GM; Guerrero ML; Salinas B; Perez-Schael I; Clemens SA; Innis B; Yarzabal JP; Vespa G; Cervantes Y; Hardt K; De Vos B
Vaccine; 2006 May; 24(18):3784-5. PubMed ID: 16098636
[TBL] [Abstract][Full Text] [Related]
26. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G
Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715
[TBL] [Abstract][Full Text] [Related]
27. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.
Tregnaghi MW; Abate HJ; Valencia A; Lopez P; Da Silveira TR; Rivera L; Rivera Medina DM; Saez-Llorens X; Gonzalez Ayala SE; De León T; Van Doorn LJ; Pilar Rubio MD; Suryakiran PV; Casellas JM; Ortega-Barria E; Smolenov IV; Han HH;
Pediatr Infect Dis J; 2011 Jun; 30(6):e103-8. PubMed ID: 21378594
[TBL] [Abstract][Full Text] [Related]
28. Rotarix®: vaccine performance 6 years postlicensure.
O'Ryan M; Lucero Y; Linhares AC
Expert Rev Vaccines; 2011 Dec; 10(12):1645-59. PubMed ID: 22085167
[TBL] [Abstract][Full Text] [Related]
29. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
Steele AD; Cunliffe N; Tumbo J; Madhi SA; De Vos B; Bouckenooghe A
J Infect Dis; 2009 Nov; 200 Suppl 1():S57-62. PubMed ID: 19817615
[TBL] [Abstract][Full Text] [Related]
30. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
[TBL] [Abstract][Full Text] [Related]
31. Rotarix (RIX4414): an oral human rotavirus vaccine.
O'Ryan M
Expert Rev Vaccines; 2007 Feb; 6(1):11-9. PubMed ID: 17280473
[TBL] [Abstract][Full Text] [Related]
32. Rotavirus vaccines: safety, efficacy and public health impact.
Gray J
J Intern Med; 2011 Sep; 270(3):206-14. PubMed ID: 21668823
[TBL] [Abstract][Full Text] [Related]
33. Rotavirus vaccination.
Bjur KA; Jacobson RM
Minerva Pediatr; 2009 Oct; 61(5):515-21. PubMed ID: 19794377
[TBL] [Abstract][Full Text] [Related]
34. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1611-4. PubMed ID: 22129995
[TBL] [Abstract][Full Text] [Related]
35. Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation.
Steele AD; Patel M; Parashar UD; Victor JC; Aguado T; Neuzil KM
J Infect Dis; 2009 Nov; 200 Suppl 1():S63-9. PubMed ID: 19817616
[TBL] [Abstract][Full Text] [Related]
36. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries.
Naghipour M; Nakagomi T; Nakagomi O
Vaccine; 2008 Jun; 26(26):3236-41. PubMed ID: 18472196
[TBL] [Abstract][Full Text] [Related]
37. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines.
Bresee JS; Hummelman E; Nelson EA; Glass RI
J Infect Dis; 2005 Sep; 192 Suppl 1():S1-5. PubMed ID: 16088790
[No Abstract] [Full Text] [Related]
38. A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.
Nakagomi T; Nakagomi O
Expert Opin Biol Ther; 2009 Aug; 9(8):1073-86. PubMed ID: 19591630
[TBL] [Abstract][Full Text] [Related]
39. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
